Kelly Coleman, Ph.D., DABT, ERT, ATS, RACDistinguished Toxicologist, Technical Fellow, Bakken Fellow at Medtronic
Kelly Coleman is a Distinguished Toxicologist and Technical Fellow at Medtronic where he provides preclinical product development support across the company. He is also a U.S. Expert on ISO Technical Committee 194’s Working Group 11, which is responsible for the medical device toxicological risk assessment standard (ISO 10993-17), and a U.S. Expert on Working Group 8, which is responsible for the medical device sensitization and irritation testing standards (ISO 10993-10 and ISO 10993-23). In this role, he co-directed a successful international round robin study which proved that 3D human skin models are suitable replacements for the rabbit skin irritation test. Kelly earned his Ph.D. in Toxicology from the University of Minnesota. He is a Diplomate of the American Board of Toxicology, a European Registered Toxicologist, a Fellow of the Academy of Toxicological Sciences, and is certified in regulatory affairs. He is a past president of the Society of Toxicology’s In Vitro and Alternative Methods Specialty Section and the Medical Device and Combination Product Specialty Section. In addition, he recently served on the National Institute of Health’s Scientific Advisory Committee on Alternative Toxicological Methods. In 2017, Kelly was inducted into Medtronic’s Bakken Society, which is the company’s highest technical honor.